Kadmon is a biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology, and genetic diseases. 

TypePublic
HQNew York, US
Founded2010
Size (employees)100 (est)-9%
Websitekadmon.com
Kadmon was founded in 2010 and is headquartered in New York, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Kadmon

Harlan Waksal

Harlan Waksal

President and Chief Executive Officer
Steven Gordon

Steven Gordon

Executive Vice President, General Counsel, Chief Administrative, Compliance and Legal Officer
John Ryan

John Ryan

Executive Vice President, Chief Medical Officer
Show more

Kadmon Office Locations

Kadmon has an office in New York
New York, US (HQ)
450 E 29th St
Show all (1)
Report incorrect company information

Kadmon Financials and Metrics

Kadmon Revenue

Kadmon's revenue was reported to be $12.26 m in FY, 2017
USD

Revenue (Q2, 2018)

792 k

Gross profit (Q2, 2018)

490 k

Gross profit margin (Q2, 2018), %

61.9%

Net income (Q2, 2018)

1.1 m

EBIT (Q2, 2018)

(36.8 m)

Market capitalization (20-Sep-2018)

378.9 m

Closing stock price (20-Sep-2018)

3.4

Cash (30-Jun-2018)

131.5 m
Kadmon's current market capitalization is $378.9 m.
Annual
USDFY, 2017

Revenue

12.3 m

Cost of goods sold

1.3 m

Gross profit

10.9 m

Gross profit Margin, %

89%
Quarterly
USDQ1, 2018Q2, 2018

Revenue

433 k792 k

Cost of goods sold

199 k302 k

Gross profit

234 k490 k

Gross profit Margin, %

54%62%
Annual
USDFY, 2017

Cash

67.5 m

Accounts Receivable

325 k

Inventories

201 k

Current Assets

70 m
Quarterly
USDQ1, 2018Q2, 2018

Cash

49.2 m131.5 m

Accounts Receivable

537 k534 k

Inventories

466 k665 k

Current Assets

51.7 m134.3 m
Annual
USDFY, 2017

Net Income

(79.8 m)

Inventories

95 k

Accounts Payable

1.6 m

Cash From Operating Activities

(64.1 m)
Quarterly
USDQ1, 2018Q2, 2018

Net Income

(20.4 m)1.1 m

Inventories

(412 k)(709 k)

Accounts Payable

285 k(2.1 m)

Cash From Operating Activities

(17.1 m)(35.3 m)
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

Kadmon News and Updates

Report incorrect company information

Kadmon Company Life and Culture

Report incorrect company information